Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Rosenberg AJ, Liao CY, Karrison T, de Souza JA, Worden FP, Libao B, Krzyzanowska MK, Hayes DN, Winquist E, Saloura V, Prescott K, Villaflor VM, Seiwert TY, Schechter RB, Stadler WM, Cohen EEW, Vokes EE. Rosenberg AJ, et al. Among authors: karrison t. Ann Oncol. 2023 Aug;34(8):714-722. doi: 10.1016/j.annonc.2023.05.002. Epub 2023 May 13. Ann Oncol. 2023. PMID: 37182801 Free PMC article. Clinical Trial.
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.
Bestvina CM, Hara JHL, Karrison T, Bowar B, Chin J, Garassino MC, Pitroda SP, Thawani R, Vokes EE, Gan G, Zhang J, Baschnagel AM, Campbell TC, Chmura S, Juloori A. Bestvina CM, et al. Among authors: karrison t. Clin Lung Cancer. 2024 Dec;25(8):e448-e452. doi: 10.1016/j.cllc.2024.08.004. Epub 2024 Aug 13. Clin Lung Cancer. 2024. PMID: 39242330 Free article. Clinical Trial.
Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant.
Derman BA, Cooperrider J, Rosenblatt J, Avigan DE, Rampurwala M, Barnidge D, Major A, Karrison T, Jiang K, Ramsland A, Kubicki T, Jakubowiak AJ. Derman BA, et al. Among authors: karrison t. Blood Cancer J. 2024 May 29;14(1):87. doi: 10.1038/s41408-024-01045-3. Blood Cancer J. 2024. PMID: 38811560 Free PMC article. Clinical Trial.
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration.
Matossian MD, Shiang C, Dolcen DN, Dreyer M, Hatogai K, Hall K, Saha P, Biernacka A, Sweis RF, Karrison T, Chen N, Nanda R, Conzen SD. Matossian MD, et al. Among authors: karrison t. Breast Cancer Res Treat. 2024 Nov 23. doi: 10.1007/s10549-024-07515-3. Online ahead of print. Breast Cancer Res Treat. 2024. PMID: 39579248
325 results